Advertisement

Ads Placeholder
Loading...

Bed Bath & Beyond Inc

BBY.DEXETRA
Consumer Cyclical
Specialty Retail
0.11
0.00(0.00%)
German Market is Open • 09:57

Bed Bath & Beyond Inc Fundamental Analysis

Bed Bath & Beyond Inc (BBY.DE) shows weak financial fundamentals with a PE ratio of -0.02, profit margin of -7.11%, and ROE of -77.13%. The company generates $12.7B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position4193.39%
PEG Ratio-0.00

Areas of Concern

ROE-77.13%
Operating Margin-2.65%
We analyze BBY.DE's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -102.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-102.3/100

We analyze BBY.DE's fundamental strength across five key dimensions:

Efficiency Score

Weak

BBY.DE struggles to generate sufficient returns from assets.

ROA > 10%
-10.91%

Valuation Score

Excellent

BBY.DE trades at attractive valuation levels.

PE < 25
-0.02
PEG Ratio < 2
-0.00

Growth Score

Moderate

BBY.DE shows steady but slowing expansion.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

BBY.DE shows balanced financial health with some risks.

Debt/Equity < 1
17.42
Current Ratio > 1
1.14

Profitability Score

Weak

BBY.DE struggles to sustain strong margins.

ROE > 15%
-7713.19%
Net Margin ≥ 15%
-7.11%
Positive Free Cash Flow
No

Key Financial Metrics

Is BBY.DE Expensive or Cheap?

P/E Ratio

BBY.DE trades at -0.02 times earnings. This suggests potential undervaluation.

-0.02

PEG Ratio

When adjusting for growth, BBY.DE's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Bed Bath & Beyond Inc at 0.07 times its book value. This may indicate undervaluation.

0.07

EV/EBITDA

Enterprise value stands at 51.89 times EBITDA. This signals the market has high growth expectations.

51.89

How Well Does BBY.DE Make Money?

Net Profit Margin

For every $100 in sales, Bed Bath & Beyond Inc keeps $-7.11 as profit after all expenses.

-7.11%

Operating Margin

Core operations generate -2.65 in profit for every $100 in revenue, before interest and taxes.

-2.65%

ROE

Management delivers $-77.13 in profit for every $100 of shareholder equity.

-77.13%

ROA

Bed Bath & Beyond Inc generates $-10.91 in profit for every $100 in assets, demonstrating efficient asset deployment.

-10.91%

Following the Money - Real Cash Generation

Operating Cash Flow

Bed Bath & Beyond Inc generates limited operating cash flow of $28.85M, signaling weaker underlying cash strength.

$28.85M

Free Cash Flow

Bed Bath & Beyond Inc generates weak or negative free cash flow of $-543.42M, restricting financial flexibility.

$-543.42M

FCF Per Share

Each share generates $-3.39 in free cash annually.

$-3.39

FCF Yield

BBY.DE converts -17.22% of its market value into free cash.

-17.22%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.02

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.07

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.002

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

17.42

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.14

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.77

vs 25 benchmark

ROA

Return on assets percentage

-0.11

vs 25 benchmark

ROCE

Return on capital employed

-0.07

vs 25 benchmark

How BBY.DE Stacks Against Its Sector Peers

MetricBBY.DE ValueSector AveragePerformance
P/E Ratio-0.0223.80 Better (Cheaper)
ROE-77.13%1105.00% Weak
Net Margin-7.11%-512.00% (disorted) Weak
Debt/Equity17.420.78 Weak (High Leverage)
Current Ratio1.142.64 Neutral
ROA-10.91%-8048.00% (disorted) Weak

BBY.DE outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Bed Bath & Beyond Inc's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Cyclical, Growth, Discretionary

EPS CAGR

N/A

Industry Style: Cyclical, Growth, Discretionary

FCF CAGR

N/A

Industry Style: Cyclical, Growth, Discretionary

Fundamental Analysis FAQ